Merck to buy WuXi Biologics' Irish vaccine facility for $500 million
3 days ago · WuXi Biologics, a Chinese biopharmaceuticals company, announced on Monday the sale of its WuXi Vaccines facility in Ireland to MSD International, a subsidiary of Merck & Co. for approximately $500 ...
WuXi Bio to Sell Vaccine Facility to Merck for $500 Million
3 days ago · WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese company seeks to enhance its margins while continuing to navigate ...
WuXi Biologics Sells Irish Vaccine Site to Merck for $500m
3 days ago · WuXi Biologics has announced the sale of its Dundalk, Ireland-based vaccine manufacturing facility to Merck for US$500 million. This news comes shortly after its parent company, WuXi AppTec, revealed plans to reduce its operational footprint. The transaction is expected to close within the first half of 2025.
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500
WuXi Biologics agreed to sell an overseas vaccine facility to Merck & Co. for half a billion dollars, a move that could strengthen the company’s cash flow and margins as it navigates global ...
Merck buys Ireland vaccines plant from troubled WuXi for €500M
3 days ago · With potential passage of the BIOSECURE Act looming, WuXi Biologics has sold a new vaccines plant in Ireland to Merck & Co. for €500 million ($521 million).
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
3 days ago · The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland. Facing increasing global pressure, WuXi Biologics will sell its Ireland vaccines facility to Merck for $500 million. The two companies have ...
Merck To Buy WuXi Biologics' Irish Vaccine Facility For $500 Mln
2 days ago · Monday, WuXi Biologics, a Chinese company, announced the sale of its WuXi Vaccines facility in Ireland to MSD International, a subsidiary of Merck & Co. , for approximately $500 million. The transaction is expected to be finalized in the first half of 2025.
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 …
WuXi Bio 2269-3.61%decrease; red down pointing triangle logics agreed to sell an overseas vaccine facility to Merck MRK 0.59%increase; green up pointing triangle & Co. for half a billion dollars ...
Merck Buys WuXi Vaccines' Irish Manufacturing Facility For
2 days ago · Merck's €500 million investment in Dundalk adds to €3 billion invested in Ireland over three years. Approximately 1,000 new jobs planned, including 150 at the Dundalk facility. The $520.1 ...
China's WuXi Biologics to sell Irish vaccine facility to Merck as US ...
3 days ago · By Sneha S K Bengaluru: China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about $500 million, ahead of potential U.S. legislation that would restrict business for Chinese biotech companies. The U.S. House of Representatives passed the Biosecure Act in September, which would ban federal contracts with targeted firms and their ...
- Some results have been removed